1. Impact of genomic profiling on the treatment and outcomes of patients with advanced gastrointestinal malignancies. (28th December 2016) Authors: Dhir, Mashaal; Choudry, Haroon A.; Holtzman, Matthew P.; Pingpank, James F.; Ahrendt, Steven A.; Zureikat, Amer H.; Hogg, Melissa E.; Bartlett, David L.; Zeh, Herbert J.; Singhi, Aatur D.; Bahary, Nathan Journal: Cancer medicine Issue: Volume 6:Number 1(2017:Jan.) Page Start: 195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis. (14th May 2019) Authors: Janssen, Quisette P; Buettner, Stefan; Suker, Mustafa; Beumer, Berend R; Addeo, Pietro; Bachellier, Philippe; Bahary, Nathan; Bekaii-Saab, Tanios; Bali, Maria A; Besselink, Marc G; Boone, Brian A; Chau, Ian; Clarke, Stephen; Dillhoff, Mary; El-Rayes, Bassel F; Frakes, Jessica M; Grose, Derek; Hos... Journal: Journal of the National Cancer Institute Issue: Volume 111:Number 8(2019) Page Start: 782 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of adjuvant chemotherapy regimen on survival outcomes in immunohistochemical subtypes of ampullary carcinoma. Issue 2 (15th December 2019) Authors: Al Abbas, Amr I.; Falvello, Virginia; Zenati, Mazen; Mani, Ashika; Hogg, Melissa E.; Zeh, Herbert J.; Singhi, Aatur; Bahary, Nathan; Zureikat, Amer H. Journal: Journal of surgical oncology Issue: Volume 121:Issue 2(2020) Page Start: 322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures. Issue 1 (10th April 2019) Authors: Singhi, Aatur D; Nikiforova, Marina N; Chennat, Jennifer; Papachristou, Georgios I; Khalid, Asif; Rabinovitz, Mordechai; Das, Rohit; Sarkaria, Savreet; Ayasso, M Samir; Wald, Abigail I; Monaco, Sara E; Nalesnik, Michael; Ohori, N Paul; Geller, David; Tsung, Allan; Zureikat, Amer H; Zeh, Herbert; ... Journal: Gut Issue: Volume 69:Issue 1(2020) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Optimal management of patients with operable pancreatic head cancer: A Markov decision analysis. Issue 5 (7th July 2021) Authors: Rieser, Caroline J.; Narayanan, Sowmya; Bahary, Nathan; Bartlett, David L.; Lee, Kenneth K.; Paniccia, Alessandro; Smith, Kenneth; Zureikat, Amer H. Journal: Journal of surgical oncology Issue: Volume 124:Issue 5(2021) Page Start: 801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 260 T cell infiltrating repertoire diversity is associated with enhanced survival following neoadjuvant therapy in patients with resectable pancreatic cancer. (9th November 2020) Authors: Murthy, Pranav; Saini, Pragosh; Russell, Kira; Pan, Wenjing; Weber, Daniel; Byrne-Steele, Miranda; Han, Jian; Espina, Viginia; Liotta, Lance; Zeh, Herbert; Bahary, Nathan; Singhi, Aatur; Bruno, Tullia; Zureikat, Amer; Lotze, Michael Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 260 T cell infiltrating repertoire diversity is associated with enhanced survival following neoadjuvant therapy in patients with resectable pancreatic cancer. (9th November 2020) Authors: Murthy, Pranav; Saini, Pragosh; Russell, Kira; Pan, Wenjing; Weber, Daniel; Byrne-Steele, Miranda; Han, Jian; Espina, Viginia; Liotta, Lance; Zeh, Herbert; Bahary, Nathan; Singhi, Aatur; Bruno, Tullia; Zureikat, Amer; Lotze, Michael Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Encouraging long‐term survival following autophagy inhibition using neoadjuvant hydroxychloroquine and gemcitabine for high‐risk patients with resectable pancreatic carcinoma. (24th September 2021) Authors: AlMasri, Samer S.; Zenati, Mazen S.; Desilva, Annissa; Nassour, Ibrahim; Boone, Brian A.; Singhi, Aatur D.; Bartlett, David L.; Liotta, Lance A.; Espina, Virginia; Loughran, Patricia; Lotze, Michael T.; Paniccia, Alessandro; Zeh, Herbert J.; Zureikat, Amer H.; Bahary, Nathan Journal: Cancer medicine Issue: Volume 10:Number 20(2021) Page Start: 7233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A phase 2 trial of regorafenib as a single agent in patients with chemotherapy‐refractory, advanced, and metastatic biliary tract adenocarcinoma. Issue 6 (18th December 2018) Authors: Sun, Weijing; Patel, Anuj; Normolle, Daniel; Patel, Krishna; Ohr, James; Lee, James J.; Bahary, Nathan; Chu, Edward; Streeter, Natalie; Drummond, Summer Journal: Cancer Issue: Volume 125:Issue 6(2019) Page Start: 902 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Overweight or Obese Individuals at Eighteen Years of Age Develop Pancreatic Adenocarcinoma at a Significantly Earlier Age. (5th June 2018) Authors: Chao, David T.; Shah, Nilesh H.; Zeh, Herbert J.; Singhi, Aatur D.; Bahary, Nathan; McGrath, Kevin M.; Fasanella, Kenneth E.; Zureikat, Amer H.; Whitcomb, David C.; Brand, Randall E. Other Names: Silvestris Nicola Academic Editor. Journal: Gastroenterology research and practice Issue: Volume 2018(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗